Talk to our team or book a consultation, in person or by telehealth.
The CDC estimates that nearly 42% of the U.S
Pharmacological mode of action of SLU-PP-332 SLU-PP-332 is a pan-ERR synthetic agonist that activates all three ERRalpha, beta, gamma paralogs with sub-micromolar potency
Statins have had a large amount of press coverage in recent years, which has led to many people having fervent opinions and potential misconceptions about this treatment choice
IP6 is capable of inhibiting MPTP, 6-OHDA, and iron toxicity in cell culture (Xu et al., 2008, 2011)
Citation on PubMed Rosine N, Rowe H, Koturan S, Yahia-Cherbal H, Leloup C, Watad A, Berenbaum F, Sellam J, Dougados M, Aimanianda V, Cuthbert R, Bridgewood C, Newton D, Bianchi E, Rogge L, McGonagle D, Miceli-Richard C